Key result
In female rats, chronic low-dose angiotensin II infusion decreased mean arterial pressure (-10 ± 2 mmHg), an effect abolished by ovariectomy (+4 ± 2 mmHg) and restored by estrogen replacement (-6 ± 2 mmHg).
Why the study?
Does estrogen replacement restore the depressor effects of chronic low-dose angiotensin II infusion in ovariectomized female rats?
Does estrogen replacement restore the depressor effects of chronic low-dose angiotensin II infusion in ovariectomized female rats?
Estrogen-dependent mechanisms offset the vasopressor actions of angiotensin II by enhancing RAS vasodilator pathways in female rats, highlighting potential therapeutic targets for women.
Answers are grounded in this paper and cite their sources.
Supports estrogen-mediated offset of Ang II effects in female rats; leaves open translation to postmenopausal hypertension therapy.
The complex role of the renin-angiotensin-system (RAS) in arterial pressure regulation has been well documented. Recently, we demonstrated that chronic low-dose angiotensin II (ANG II) infusion decreases arterial pressure in female rats via an AT(2)R-mediated mechanism. Estrogen can differentially regulate components of the RAS and is known to influence arterial pressure regulation. We hypothesized that AT(2)R-mediated depressor effects evident in females were estrogen dependent and thus would be abolished by ovariectomy and restored by estrogen replacement. Female Sprague-Dawley rats underwent ovariectomy or sham surgery and were treated with 17β-estradiol or placebo. Mean arterial pressure (MAP) was measured via telemetry in response to a 2-wk infusion of ANG II (50 ng·kg(-1)·min(-1) sc) or saline. MAP significantly decreased in females treated with ANG II (-10 ± 2 mmHg), a response that was abolished by ovariectomy (+4 ± 2 mmHg) and restored with estrogen replacement (-6 ± 2 mmHg). Cardiac and renal gene expression of components of the RAS was differentially regulated by estrogen, such that overall, estrogen shifted the balance of the RAS toward the vasodilatory axis. In conclusion, estrogen-dependent mechanisms offset the vasopressor actions of ANG II by enhancing RAS vasodilator pathways in females. This highlights the potential for these vasodilator pathways as therapeutic targets, particularly in women.
No takes yet. Share an insight, caveat, or question.
Sampson et al. (2011) studied Arterial pressure regulation. Chronic low-dose angiotensin II (ANG II) infusion and estrogen replacement vs. Saline / ovariectomy without estrogen replacement was evaluated on Mean arterial pressure (MAP). In female rats, chronic low-dose angiotensin II infusion decreased mean arterial pressure (-10 ± 2 mmHg), an effect abolished by ovariectomy (+4 ± 2 mmHg) and restored by estrogen replacement (-6 ± 2 mmHg).
Synapse has enriched 10 related papers. Consider them for comparative context: